International guidelines for the selection of lung transplant candidates

…, LL Schulman, G Simmoneau… - American journal of …, 1998 - profiles.wustl.edu
International guidelines for the selection of lung transplant candidates — Research Profiles at
Washington University School of Medicine Skip to main navigation Skip to search Skip to main …

Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension

S Harari, F Brenot, M Barberis, G Simmoneau - Chest, 1997 - journal.chestnet.org
1 Maltais F, Laberge F, Laviolette M. A randomized, doubleblind, placebo-controlled study of
lorazepam as premedication for bronchoscopy. Chest 1996; 110: 1195-98 2 Hatton MQF …

Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial.

P Petitpretz, G Simmoneau, J Cerrina, D Musset… - Circulation, 1984 - Am Heart Assoc
To evaluate hemodynamic, angiographic, and biological effects of a single bolus of
urokinase, an open descriptive trial was conducted in a homogeneous group of 14 patients …

Sustained Plasma Concentrations of Treprostinil Following Chronic Dosing in Patients with Pulmonary Arterial Hypertension (PAH).

…, D Mottola, N Galie, G Simmoneau… - B55. PULMONARY …, 2009 - atsjournals.org
Treprostinil (TRE) diethanolamine sustained release tablets (UT− 15C SR) are being
evaluated as treatment for PAH. UT− 15C is the diethanolamine salt of the prostanoid …

Cardiovascular response to the IV administration of morphine in critically ill patients undergoing IPPV

JJ Rouby, P Glaser, G Simmoneau, G Gory… - British Journal of …, 1979 - Elsevier
The haemodynamic changes following the administration of morphine 0.15 and 0.30 mg kg−
1 iv were studied in 11 patients, free from known cardiac disease. All patients were acutely ill …

Illicit drug use and pulmonary arterial hypertension: Not so frequent

…, N Favrolt, J Traclet, V Cottin, O Sitbon, G Simmoneau… - 2016 - Eur Respiratory Soc
Background: Some drugs are recognized risk factors of pulmonary arterial hypertension
(PAH). Datas confirming a link between illicit drug use and PAH are limited. We tried to find …

The severity of pulmonary hypertension is related to decreased left ventricular dimension, not to increased right ventricular dimension: a CMR study

…, X Jais, O Sitbon, M Humbert, G Simmoneau… - 2011 - epos.myesr.org
Purpose• Pulmonary hypertension (PH) is associated with right ventricular (RV) pressure
overload.• RV overload leads to increased RV dimension, interventricular septum bulging …

Long-term outcome after percutaneous shunt closure of selected patients with atrial septal defect and severe pulmonary hypertension

M Tortigue, M Humbert, O Sitbon, G Simmoneau… - Archives of …, 2019 - Elsevier
Background Pulmonary arterial hypertension (PAH) is a dreaded complication of ostium
secundum atrial septal defects (ASD). Shunt closure indication remains controversial in …

Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension

…, C Guignabert, L Tu, C Francois, G Simmoneau… - 2011 - Eur Respiratory Soc
Studies have reported over-activation of the sympathetic nerve system (SNS) in patients with
idiopathic Pulmonary Arterial Hypertension (iPAH). Since the Renin-Angiotensin-Aldosteron …

[HTML][HTML] Further positive Opsumit (macitentan) data in pulmonary arterial hypertension presented at CHEST 2013

G Simmoneau, R Channick, M Delcroix, N Galiè… - informazione.it
Actelion Pharmaceuticals Ltd/Further positive Opsumit (macitentan) data in pulmonary
arterial hypertension presented at CHEST 2013. Processed and transmitted by Thomson …